Magnesium bioavailability from magnesium citrate and magnesium oxide
- PMID: 2407766
- DOI: 10.1080/07315724.1990.10720349
Magnesium bioavailability from magnesium citrate and magnesium oxide
Abstract
This study compared magnesium oxide and magnesium citrate with respect to in vitro solubility and in vivo gastrointestinal absorbability. The solubility of 25 mmol magnesium citrate and magnesium oxide was examined in vitro in solutions containing varying amounts of hydrochloric acid (0-24.2 mEq) in 300 ml distilled water intended to mimic achlorhydric to peak acid secretory states. Magnesium oxide was virtually insoluble in water and only 43% soluble in simulated peak acid secretion (24.2 mEq hydrochloric acid/300 ml). Magnesium citrate had high solubility even in water (55%) and was substantially more soluble than magnesium oxide in all states of acid secretion. Reprecipitation of magnesium citrate and magnesium oxide did not occur when the filtrates from the solubility studies were titrated to pH 6 and 7 to stimulate pancreatic bicarbonate secretion. Approximately 65% of magnesium citrate was complexed as soluble magnesium citrate, whereas magnesium complexation was not present in the magnesium oxide system. Magnesium absorption from the two magnesium salts was measured in vivo in normal volunteers by assessing the rise in urinary magnesium following oral magnesium load. The increment in urinary magnesium following magnesium citrate load (25 mmol) was significantly higher than that obtained from magnesium oxide load (during 4 hours post-load, 0.22 vs 0.006 mg/mg creatinine, p less than 0.05; during second 2 hours post-load, 0.035 vs 0.008 mg/mg creatinine, p less than 0.05). Thus, magnesium citrate was more soluble and bioavailable than magnesium oxide.
Similar articles
-
A model system for assessing physicochemical factors affecting calcium absorbability from the intestinal tract.J Bone Miner Res. 1989 Feb;4(1):119-27. doi: 10.1002/jbmr.5650040117. J Bone Miner Res. 1989. PMID: 2718774
-
Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.J Urol. 1991 Feb;145(2):330-4. doi: 10.1016/s0022-5347(17)38330-1. J Urol. 1991. PMID: 1988724 Clinical Trial.
-
Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction.J Urol. 1990 Feb;143(2):248-51. doi: 10.1016/s0022-5347(17)39924-x. J Urol. 1990. PMID: 2299712
-
Management of primary hyperoxaluria: efficacy of oral citrate administration.Pediatr Nephrol. 1993 Apr;7(2):207-11. doi: 10.1007/BF00864405. Pediatr Nephrol. 1993. PMID: 8476722 Review.
-
Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans.Am J Ther. 2001 Sep-Oct;8(5):345-57. doi: 10.1097/00045391-200109000-00008. Am J Ther. 2001. PMID: 11550076 Review.
Cited by
-
Mechanism of urinary calcium regulation by urinary magnesium and pH.J Am Soc Nephrol. 2008 Aug;19(8):1530-7. doi: 10.1681/ASN.2007091038. Epub 2008 Apr 30. J Am Soc Nephrol. 2008. PMID: 18448585 Free PMC article.
-
Evaluating the effectiveness of adding magnesium chloride to conventional protocol of citrate alkali therapy on kidney stone size.Adv Biomed Res. 2016 Oct 26;5:168. doi: 10.4103/2277-9175.192629. eCollection 2016. Adv Biomed Res. 2016. PMID: 27995107 Free PMC article.
-
Magnesium Oxide in Constipation.Nutrients. 2021 Jan 28;13(2):421. doi: 10.3390/nu13020421. Nutrients. 2021. PMID: 33525523 Free PMC article. Review.
-
Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes.Nutrients. 2021 Jan 22;13(2):320. doi: 10.3390/nu13020320. Nutrients. 2021. PMID: 33499378 Free PMC article. Review.
-
Antacid attenuates the laxative action of magnesia in cancer patients receiving opioid analgesic.J Pharm Pharmacol. 2016 Sep;68(9):1214-21. doi: 10.1111/jphp.12600. Epub 2016 Jun 30. J Pharm Pharmacol. 2016. PMID: 27364763 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources